Kanamycin

Revision as of 15:35, 6 January 2014 by Gerald Chi (talk | contribs)
Jump to navigation Jump to search
Kanamycin
KANAMYCIN® Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Kanamycin sulfate is an aminoglycoside antibiotic, available in both oral and intravenous forms, and used to treat a wide variety ofinfections. Kanamycin is isolated from Streptomyces kanamyceticus.

Category

Aminoglycoside

US Brand Names

KANAMYCIN® (DISCONTINUED), KANAMYCIN SULFATE® (DISCONTINUED), KANTREX® (DISCONTINUED), KLEBCIL® (DISCONTINUED)

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

Kanamycin works by affecting the 30S ribosomal subunit and causing a frameshift mutation or it prevents the translation of RNA.

Because of over-usage of antibiotics many bacteria have developed a resistance against kanamycin, and, consequently, it is not used much anymore.

References


Pharmacology

Side effects

Common side effects include changes in hearing (either hearing loss or ringing in the ears), toxicity to kidneys, and allergic reactions to the drug.

Use in Research

Genes encoding kanamycin resistance are commonly used as selectable markers in molecular biology.